Oncotelic Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 11.00 thousand shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2019-05-15
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 11.00K shares, a 93.71% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-12-31 was 1.00K shares, a 99.85% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-09-30 was 533.00K shares, a 41.76% increase year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-06-30 was 419.00K shares, a 16.71% increase year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 1.13M shares, a 36.66% decline from fiscal 2017.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 1.78M shares, a 321.04% increase from fiscal 2016.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 423.00K shares, a 12.42% decline from fiscal 2015.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 483.00K shares, a 1078.05% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2019-03-31 | 11.00K shares 10-Q · filed 2019-05-15 | 12.00K shares derived: sum of 2 quarters · filed 2019-05-15 | 545.00K shares derived: sum of 3 quarters · filed 2019-05-15 | 964.00K shares derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-12-31 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | 534.00K shares derived: sum of 2 quarters · filed 2019-04-10 | 953.00K shares derived: sum of 3 quarters · filed 2019-04-10 | 1.13M shares 10-K · filed 2019-04-10 |
| 2018-09-30 | 533.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 952.00K shares derived: sum of 2 quarters · filed 2018-11-14 | 1.13M shares 10-Q · filed 2018-11-14 | 1.81M shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-06-30 | 419.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 594.00K shares 10-Q · filed 2018-08-14 | 1.28M shares derived: sum of 3 quarters · filed 2019-04-10 | 1.66M shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-03-31 | 175.00K shares 10-Q · filed 2018-05-14 | 860.00K shares derived: sum of 2 quarters · filed 2019-04-10 | 1.24M shares derived: sum of 3 quarters · filed 2019-04-10 | 1.59M shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2017-12-31 | 685.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | 1.06M shares derived: sum of 2 quarters · filed 2019-04-10 | 1.42M shares derived: sum of 3 quarters · filed 2019-04-10 | 1.78M shares 10-K · filed 2019-04-10 |
| 2017-09-30 | 376.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 735.00K shares derived: sum of 2 quarters · filed 2017-11-14 | 1.10M shares 10-Q · filed 2017-11-14 | 1.30M shares derived: sum of 4 quarters · filed 2018-04-17 |
| 2017-06-30 | 359.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 720.00K shares 10-Q · filed 2017-08-02 | 923.00K shares derived: sum of 3 quarters · filed 2018-04-17 | 1.03M shares derived: sum of 4 quarters · filed 2018-04-17 |
| 2017-03-31 | 361.00K shares 10-Q · filed 2017-05-08 | 564.00K shares derived: sum of 2 quarters · filed 2018-04-17 | 669.00K shares derived: sum of 3 quarters · filed 2018-04-17 | 672.00K shares derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-12-31 | 203.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | 308.00K shares derived: sum of 2 quarters · filed 2018-04-17 | 311.00K shares derived: sum of 3 quarters · filed 2018-04-17 | 423.00K shares 10-K · filed 2018-04-17 |
| 2016-09-30 | 105.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 108.00K shares derived: sum of 2 quarters · filed 2016-11-14 | 220.00K shares 10-Q · filed 2016-11-14 | 431.00K shares derived: sum of 4 quarters · filed 2017-03-30 |
| 2016-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 115.00K shares 10-Q · filed 2016-08-02 | 326.00K shares derived: sum of 3 quarters · filed 2017-03-30 | 408.00K shares derived: sum of 4 quarters · filed 2017-03-30 |
| 2016-03-31 | 112.00K shares 10-Q · filed 2016-05-06 | 323.00K shares derived: sum of 2 quarters · filed 2017-03-30 | 405.00K shares derived: sum of 3 quarters · filed 2017-03-30 | |
| 2015-12-31 | 211.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 293.00K shares derived: sum of 2 quarters · filed 2017-03-30 | 483.00K shares 10-K · filed 2017-03-30 | |
| 2015-09-30 | 82.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 272.00K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 190.00K shares 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | 41.00K shares 10-K · filed 2016-03-25 |